P/E ratio for LeMaitre Vascular (LMAT)
P/E ratio as of June 2023 (TTM): 69.1
According to LeMaitre Vascular's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 69.0532. At the end of 2021 the company had a P/E ratio of 39.6.
P/E ratio history for LeMaitre Vascular from 2007 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 39.6 | 2.54% |
| 2020 | 38.6 | -3.44% |
| 2019 | 39.9 | 99.38% |
| 2018 | 20.0 | -43.37% |
| 2017 | 35.4 | -20.42% |
| 2016 | 44.5 | 13.4% |
| 2015 | 39.2 | 17.87% |
| 2014 | 33.3 | -8.65% |
| 2013 | 36.4 | 7.83% |
| 2012 | 33.8 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Baxter BAX | -8.56 | -112.39% | 🇺🇸 USA |
 Boston Scientific BSX | 87.8 | 27.19% | 🇺🇸 USA |
 Edwards Lifesciences EW | 35.4 | -48.72% | 🇺🇸 USA |
 Teleflex TFX | 30.6 | -55.70% | 🇺🇸 USA |
 AngioDynamics ANGO | -10.6 | -115.38% | 🇺🇸 USA |
 Cardiovascular Systems CSII | -20.6 | -129.86% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.